About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
The Technical Alignment Subcommittee (TASC) supports harmonisation, interoperability, and technical alignment across GA4GH products.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
28 May 2024
The GA4GH Regulatory and Ethics Work Stream (REWS) compiled and submitted comments to the WHO regarding its draft principles for human genome access, use, and sharing.
By Jaclyn Estrin, GA4GH Science Writer
In April 2024, the World Health Organization (WHO) requested public comment on its draft principles for human genome access, use, and sharing.
The Global Alliance for Genomics and Health (GA4GH) Regulatory and Ethics Work Stream (REWS) coordinated a collective response to the WHO’s request for comments, conveying the expertise and feedback of the GA4GH contributor community.
Genomic data holds sensitive information related to people’s identity and health histories. The WHO designed its draft principles to enable responsible genomic data sharing to advance global health research, while simultaneously protecting patients’ personal information. The document intends to offer a blueprint in governing the complete genomic data lifecycle: promoting inclusion, trust, and integrity in genomic data sharing, as well as highlighting its benefits at both individual and communal levels.
GA4GH’s mission is to develop harmonised standards to allow for the safe and responsible sharing and use of genomic data. Within GA4GH, REWS develops guidance on the regulatory, ethical, and social considerations that arise within genomic research and international data sharing. The organisation’s foundational commitments to the protection of human rights, set forth in the Framework for Responsible Sharing of Genomic and Health-related Data (known as the Framework), developed by REWS in 2013, guides the development of all GA4GH products.
GA4GH has a strong interest in ensuring policies align with existing international conventions, regulations, codes, and policies, promoting a globally standardised approach to data sharing that is grounded in the fundamental acknowledgement of human rights.
The GA4GH Framework emphasises that responsible data and knowledge sharing advances the human right to benefit from science by breaking down scientific and data silos. In its comments submitted to the WHO, GA4GH underscored the importance of embedding explicit mentions of human rights within its principles, including the right to privacy, the right to health security, and the right of all to partake in scientific advancement, along with its associated benefits.
Vast amounts of genomic data exist across institutions, research centres, universities, and repositories around the world. The sharing of genomic data is imperative to drive collaborative scientific advancements in biomedical research and foster a greater understanding of human health.
Therefore, GA4GH advised the WHO to recognise human genomic data as a public good with the power to benefit human health and the global research ecosystem. At the same time, data sharing efforts must respect the preferences and prior consents of patients and research participants. GA4GH recommends that consent processes be highly specified about the potential uses of an individual’s data — whether that be in the clinical setting for primary studies or for use in secondary research.
To ensure that the promise of genomics benefits all people globally, GA4GH crucially reminded the WHO to explicitly discuss the importance of sharing datasets that include contributions from donors of diverse ethnicities and backgrounds, particularly those from underrepresented communities. Diverse datasets can better promote equity in genomics and advance the potential of precision medicine. For more perspective on diversity in datasets, please see the GA4GH REWS Diversity in Datasets policy.
A copy of GA4GH’s comments on the WHO’s draft policy was submitted to the open access research platform, SSRN, where it is currently under review. The SSRN link to the PDF document will be made available to the scientific community on the GA4GH REWS webpage once it is published.
GA4GH’s comments on the WHO’s draft policy demonstrate GA4GH’s commitment to a harmonised approach to the development of global genomic data sharing standards that ensure the ethical and responsible use of genomic and health-related data.
—
Amendment 7 June 2024: GA4GH’s submission to the SSRN was accepted and is now available as a preprint. The SSRN link to the PDF document can be found linked here and is available to the scientific community on the GA4GH REWS webpage.